Is the CSL share price a buy?

Is the CSL Limited (ASX:CSL) share price a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Is the CSL Limited (ASX: CSL) share price a buy?

It's been a pretty decent month for CSL so far. Since the start of March the CSL share price is up from $193.76 to $198.97 at the time of writing.

Some of the rise can be attributed to the rise in the value of the ASX share market, but it could also be attributed to the returning confidence of investors in CSL.

The US Federal Reserve has recently signalled that it is much closer to the market neutral rate than previously thought. This provides support for higher valuations for growth shares like CSL. Interest rates act like gravity, the lower the interest rate the higher the theoretical valuation should be.

CSL is now trading at nearly 34x FY19's estimated earnings again, which is quite expensive considering CSL predicted that net profit will come in at US$1.88 billion to US$1.95 billion in FY19, being growth of 10% to 14%, although the biotech company recently updated the market to say it expects the figure to be at the high end of this range.

The company may need to have a strong second half to achieve its targets considering revenue grew by 11% at constant currency to US$4.5 billion in the recently-reported FY19 half-year result, earnings before interest and tax (EBIT) increased by 6% to US$1.55 billion and earnings per share (EPS) grew by 10% to US$2.56 per share.

One of the great things about CSL is that it's constantly investing for the future. In FY19 it plans to open 30 to 35 new collection centres for plasma.

The biotechnology company is also always in a research & development cycle for new products, which will create new revenue streams as they come online. For example, CSL said there are five new products going into human clinical trials.

One of the added bonuses about CSL is its growing dividend. In Australian dollar terms, CSL just grew its interim dividend by 20%, which was another raise after many years of increases.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

Here are the top five ASX 200 shares in Macquarie's model growth portfolio

These ASX 200 shares are highly rated by analysts at Macquarie.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX shares to buy in 2024 and hold for the next 10 years

Analysts think these top shares are in the buy zone right now.

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Growth Shares

4 ASX growth shares I think will benefit from interest rate cuts in 2024

Not only will home loan holders rejoice, investors of these stocks could also be yelling with joy when the Reserve…

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Growth Shares

3 of the best ASX growth shares to buy now

Analysts see plenty of upside for these buy-rated shares.

Read more »

A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
Growth Shares

Here's why analysts love these buy-rated ASX 200 growth shares

There's a reason analysts are feeling bullish about these companies.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

Big returns could be coming for high-flying Lovisa shares

Morgans doesn't believe it is too late to snap up this hot stock.

Read more »

Smiling young parents with their daughter dream of success.
Growth Shares

Why these ASX 200 growth shares could be top buys now

Analysts are feeling bullish about these growth stocks. Let’s see what they’re saying.

Read more »

Concept image of a man in a suit with his chest on fire.
Growth Shares

Ignore the noise and buy this hot ASX growth stock

A recent pullback may have created a buying opportunity according to Bell Potter.

Read more »